Nail dystrophy due to dose-intensive chemotherapy

Int J Hematol. 2009 Jul;90(1):6-7. doi: 10.1007/s12185-009-0355-9. Epub 2009 Jun 20.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Etoposide / administration & dosage
  • Etoposide / adverse effects
  • Female
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / pathology*
  • Humans
  • Male
  • Nail Diseases / chemically induced*
  • Nail Diseases / pathology*
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Procarbazine / administration & dosage
  • Procarbazine / adverse effects
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Bleomycin
  • Procarbazine
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • BEACOPP protocol